Business Context and Reporting Period
This Form 8-K Current Report was filed by Tempur-Pedic International Inc. on December 21, 2005, covering events that occurred on December 15, 2005. The filing details material definitive agreements regarding equity compensation and stock option vesting adjustments.
Key Financial Metrics
The filing does not provide standard financial performance metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The only financial figures disclosed relate to specific equity compensation transactions:
- Option Exercise Price: $12.37 per share for new grants.
- Weighted Average Exercise Price (Accelerated Options): $18.20 per share.
- Avoided Pre-tax Charge: Approximately $3 million over an average period of 2.69 years.
Material Changes
The primary material change reported is the acceleration of vesting for approximately 467,000 unvested stock options (representing 18% of outstanding unvested options). This action was taken to avoid recognizing future compensation expense associated with these "out-of-the-money" options following the adoption of FASB Statement No. 123R. Additionally, new stock options were granted to executive officers and directors.
Guidance, Outlook, and Management Commentary
Management commentary indicates the acceleration of vesting is a strategic move to align with new accounting standards (FASB 123R) and prevent future expense recognition. The accelerated vesting is conditioned on recipients entering into Stock Sale Restriction Agreements, which prohibit the sale or transfer of shares acquired from the accelerated options until the original vesting date would have occurred. No forward-looking financial guidance or revenue outlook is provided in this filing.
Important Facts for Investor Verification
- Verify the total number of shares granted: 150,000 to Executive Vice President Matthew Clift and 15,000 each to directors Nancy Koehn and Sir Paul Judge.
- Confirm the impact of the $3 million avoided pre-tax charge on future earnings per share calculations.
- Review the terms of the Stock Sale Restriction Agreements to understand the liquidity constraints placed on executives and directors regarding the accelerated options.
- Note that the filing text does not provide a clear value for the company's current cash position, debt levels, or operating revenue.